alexa Economic issues in postexposure rabies treatment.


Journal of Vaccines & Vaccination

Author(s): Wilde H, Tipkong P, Khawplod P

Abstract Share this page

Abstract Rabies remains a worldwide public health problem even though means to control this disease are known. Logistic problems and cultural barriers for effective dog control in many countries and the high cost of human postexposure treatment, account for much of the remaining worldwide human toll. Efforts to make vaccines, with effective and safe tissue or avian culture products and immune globulin, more affordable have been only marginally successful. Second generation rabies vaccines (purified Vero-, chick and duck embryo cell products) are effective, safe and less expensive than human diploid cell rabies vaccine. Reduced dose intradermal postexposure vaccination works, is affordable, and has helped abolish the use of dangerous and poorly immunogenic brain tissue-derived vaccines in Thailand, the Philippines, and Sri Lanka. The use of purified equine rabies immune globulin has been found to be safe and cost-effective. It is, unfortunately, in short supply worldwide. Preexposure rabies vaccination for travelers to endemic regions is recommended and should be administered by the intramuscular route whenever possible.
This article was published in J Travel Med and referenced in Journal of Vaccines & Vaccination

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version